Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

206.92 -0.64 (-0.31%)
Official Closing Price Updated: 5:00 PM EST, Nov 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
U.S. Economy Flashes Warning Signs: Federal Reserve Navigates Data Void Amidst Slowdown
The United States economy is exhibiting increasingly clear signs of a significant slowdown, creating a complex and challenging environment for policymakers at the Federal Reserve. A decelerating labor... 
Via MarketMinute
Topics Bonds Economy Stocks
News headline image
The Fear Index Flares: VIX Soars as Valuation Concerns Rattle US Markets
The US stock market experienced a significant jolt today, November 18, 2025, as the 'fear index,' or CBOE Volatility Index (VIX), surged dramatically. This sharp rise signals a palpable increase in... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Healthcare Sector Navigates Volatile Markets: A Defensive Anchor or Driven by Innovation?
As broader markets grapple with persistent volatility on November 18, 2025, the healthcare sector within the S&P 500 (SPX) finds itself under intense scrutiny. Traditionally viewed as a stalwart... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Amazon Stumbles: AI Bubble Fears, Downgrade Drive Tech Giant's Steep Decline
Amazon (NASDAQ: AMZN) emerged as a significant laggard on the Dow Jones Industrial Average today, November 18, 2025, as its shares experienced a notable decline. This downturn contributed to a broader... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Bank of America Flashes "Sell Signal" as Investor Cash Dries Up, Raising Market Stability Concerns
Bank of America (NYSE: BAC) has recently sounded a significant alarm for the stock market, issuing a "sell signal" that has sent ripples of concern through the financial world. This cautionary... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Market Tremors: S&P 500 Faces Longest Losing Streak in Months as AI Doubts and Fed Hawks Reign
The U.S. stock market is currently navigating a turbulent period, marked by significant declines across all major indices and a notable four-day losing streak for the S&P 500, its longest such run... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
10 Years Later: 5 Lesser-Known Rule Breakers ↗
We're back with the second episode of a new series -- 10 Years Later -- where we blast through time to check in on a five-stock sampler from 10 years in the past. 
Via The Motley Fool
News headline image
Navigating the Tempest: Understanding and Thriving Amidst November 2025's Surging Market Volatility
As November 2025 unfolds, global financial markets are caught in a relentless tempest of volatility, characterized by rapid and often dramatic price swings. Investor sentiment has grown increasingly... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Markets Brace for Impact: A Deep Dive into the Global "Risk-Off" Mood
Global financial markets are currently gripped by a palpable "risk-off" sentiment, sending investors scurrying away from speculative assets and towards the perceived safety of traditional havens. This... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Market Reels on November 18, 2025: Tech Valuations, AI Bubble Fears, and Fading Rate Cut Hopes Trigger Broad Sell-Off
New York, NY – November 18, 2025 – Global stock markets experienced a significant plunge today, November 18, 2025, with major U.S. indices hitting multi-week lows as investor sentiment soured... 
Via MarketMinute
Topics Artificial Intelligence Economy Lawsuit
News headline image
3 Smart Defensive Stocks for an Uneasy Market ↗
Via MarketBeat
News headline image
Wall Street Stumbles Ahead of Nvidia’s Big Moment ↗
A cautious start to the week as investors brace for a flood of economic data and Nvidia’s highly anticipated earnings. 
Via Chartmill
News headline image
Geopolitical Undercurrents Propel Greenback, Reshaping Global Commodity Landscape
In a period marked by escalating global tensions and economic uncertainty, the US Dollar (Greenback) is exhibiting robust strength, driven by a complex interplay of geopolitical factors and the Federal... 
Via MarketMinute
Topics Bonds Economy Energy
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation. 
Via Benzinga
Topics ETFs
News headline image
Dow Plunges Amid Economic Fears: A Closer Look at the Market's Tumultuous Week
The Dow Jones Industrial Average experienced a significant setback today, November 17, 2025, plummeting by approximately 800 points as mounting concerns over the health of the U.S. economy gripped... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Consumer Brands Shake Things Up...With Mergers ↗
2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting... 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Johnson & Johnson Adds Prostate Cancer Candidate In Around $3 Billion Halda Deal ↗
Johnson & Johnson buys Halda for $3.05 billion, adding a prostate cancer candidate as new Tremfya Phase 3b data show sustained benefits through 48 weeks. 
Via Benzinga
News headline image
Valuation Fears Ignite "Great Rotation" in Global Markets as Investors Seek Shelter from Elevated Prices
Global financial markets are currently gripped by a palpable sense of unease, as elevated valuations, particularly within the high-flying technology and Artificial Intelligence (AI) sectors, spark... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Dispute ↗
Texas judge rejects bid to block Kenvue's $398 million dividend and declines to restrict Tylenol marketing as the company faces a lawsuit over pregnancy safety claims. 
Via Benzinga
Topics Lawsuit
News headline image
Navigating the Tides: Long-Term Investment Strategies for a Fluctuating Stock Market
In a financial landscape perpetually shaped by unpredictability, long-term investment strategies emerge as the crucial anchor for investors navigating the volatile stock market. As of November 17,... 
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
News headline image
Navigating the Tempest: Market Volatility Surges Amidst Investor Caution and Economic Uncertainty
As November 2025 unfolds, global financial markets find themselves in a turbulent sea of heightened volatility, prompting a pervasive sense of caution among investors. A complex interplay of economic... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
Labor Market Jitters Send Shockwaves Through Wall Street: Investors Brace for Economic Slowdown Amidst Delayed Data
The financial markets are grappling with a turbulent period as recent labor market reports, particularly those reflecting October 2025 data, paint a picture of a weakening economy. With official... 
Via MarketMinute
Topics Bonds Economy Stocks
News headline image
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment ↗
Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics. 
Via Investor's Business Daily
News headline image
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
From Johnson & Johnson
Via Business Wire
News headline image
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Federal Reserve's Hawkish Stance Crushes Gold and Silver, Dashing December Rate Cut Hopes
Washington D.C. – November 14, 2025 – Recent hawkish pronouncements from Federal Reserve officials have sent shockwaves through the financial markets, particularly impacting precious metals. Gold and... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development
The pharmaceutical industry is on the cusp of a profound transformation, driven by the synergistic power of artificial intelligence (AI) and digital twins. These cutting-edge technologies are rapidly... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Global Markets Shaken by AI Concerns and Rate Cut Doubts, Wall Street Stages Volatile Recovery
New York, NY – November 14, 2025 – Global financial markets have recently experienced a significant upheaval, marked by a sharp stock selloff driven primarily by escalating concerns over the lofty... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy ↗
Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and stroke studies continue with data expected in 2026. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.